Tumor-infiltrating immune cells in the TME can independently be adopt to predict sentinel lymph node status and patient survival, and the above findings support a prognostic role of MTHFD2 in pan-cancer [4, 24]. The gene discussed is MTHFD2; the disease is neoplasm.